Clinical trial
Sargramostim in Decreasing Mucositis in Patients Receiving Radiation Therapy for…
NCT00008398 · Radiation Therapy Oncology Group, Other · Completed
Key facts
| NCT number | NCT00008398 |
|---|---|
| Title | Sargramostim in Decreasing Mucositis in Patients Receiving Radiation Therapy for Head and Neck Cancer |
| Official title | A Phase III Study to Test the Efficacy and Safety of GM-CSF to Reduce the Severity and Duration of Mucosal Injury and Pain (Mucositis) Associated With Curative Radiation Therapy in Head and Neck Cancer Patients |
| Lead sponsor | Radiation Therapy Oncology Group, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Head and Neck Cancer, Oral Complications, Radiation Toxicity |
| Intervention type | Biological, Procedure, Radiation |
| Interventions | sargramostim, quality-of-life assessment, radiation therapy |
| Start date | Oct 1, 2000 |
| Primary completion | Mar 1, 2004 |
| First posted | Jun 5, 2003 |
| Last update posted | Nov 19, 2013 |
| Countries | Canada, United States |
At a glance
- 100–999 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: